{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:30:41Z","timestamp":1787671841290,"version":"build-2736575974"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007229","name":"Harvard University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023548","name":"Instytut Pomnik - Centrum Zdrowia Dziecka","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023548","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ymgme.2026.110112","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:58:25Z","timestamp":1775145505000},"page":"110112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between heterozygous GBA1 L444P carrier status and risk of Parkinson's disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"148","author":[{"given":"Agnieszka","family":"Jurecka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelle","family":"Siegfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Chen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2026.110112_bb0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejim.2013.09.006","article-title":"Gaucher disease: a diagnostic challenge for internists","volume":"25","author":"Cassinerio","year":"2014","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ymgme.2026.110112_bb0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ymgme.2016.11.006","article-title":"Gaucher disease: progress and ongoing challenges","volume":"120","author":"Mistry","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110112_bb0015","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bcmd.2010.07.015","article-title":"Gaucher disease and dysgammaglobulinemia: a report of 61 patients, including 18 with GD type III","volume":"46","author":"Jurecka","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2026.110112_bb0020","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ymgme.2026.110112_bb0025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10545-009-9009-6","article-title":"Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the international collaborative Gaucher group neurological outcomes subregistry","volume":"33","author":"Tylki-Szymanska","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110112_bb0030","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","article-title":"Occurrence of Parkinson's syndrome in type I Gaucher disease","volume":"89","author":"Neudorfer","year":"1996","journal-title":"QJM"},{"key":"10.1016\/j.ymgme.2026.110112_bb0035","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jmg.2004.024455","article-title":"Parkinsonism among Gaucher disease carriers","volume":"41","author":"Goker-Alpan","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2026.110112_bb0040","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.bcmd.2006.02.004","article-title":"Increased incidence of Parkinson disease among relatives of patients with gaucher disease","volume":"36","author":"Halperin","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2026.110112_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/genes15121605","article-title":"A global perspective of GBA1-related Parkinson\u2019s disease: a narrative review","volume":"15","author":"Koros","year":"2024","journal-title":"Genes"},{"key":"10.1016\/j.ymgme.2026.110112_bb0050","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2026.110112_bb0055","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1212\/01.wnl.0000304039.11891.29","article-title":"Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset","volume":"70","author":"Gan-Or","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2026.110112_bb0060","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.24777","article-title":"Survival and dementia in GBA-associated Parkinson\u2019s disease: the mutation matters","volume":"80","author":"Cilia","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2026.110112_bb0065","first-page":"85","article-title":"International multi-center analysis of glucocerebrosidase mutations in Parkinson disease","volume":"98","author":"Sidransky","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110112_bb0070","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1212\/WNL.0b013e318225ab77","article-title":"GBA-associated PD presents with nonmotor characteristics","volume":"77","author":"Brockmann","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2026.110112_bb0075","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.wnl.0000276989.17578.02","article-title":"Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease","volume":"69","author":"Clark","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2026.110112_bb0080","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/mds.25248","article-title":"The glucocerobrosidase E326K variant predisposes to Parkinson\u2019s disease, but does not cause Gaucher\u2019s disease","volume":"28","author":"Duran","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ymgme.2026.110112_bb0085","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/brain\/aws318","article-title":"Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort","volume":"136","author":"Winder-Rhodes","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2026.110112_bb0090","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s13023-022-02517-0","article-title":"Rare lysosomal disease registries: lessons learned over three decades of real-world evidence","volume":"17","author":"Mistry","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.110112_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.679927","article-title":"Neurodegenerative disease risk in carriers of autosomal recessive disease","volume":"12","author":"Vieira","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ymgme.2026.110112_bb0100","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1179\/1743132813Y.0000000224","article-title":"Mutations in GBA and risk of Parkinson\u2019s disease: a meta-analysis based on 25 case-control studies","volume":"35","author":"Mao","year":"2013","journal-title":"Neurol. Res."},{"key":"10.1016\/j.ymgme.2026.110112_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2018.00043","article-title":"Integrated genetic analysis of racial differences of common GBA variants in Parkinson\u2019s disease: a meta-analysis","volume":"11","author":"Zhang","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymgme.2026.110112_bb0110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10654-019-00576-5","article-title":"A 24-step guide on how to design, conduct, and successfully publish a systematic review and meta-analysis in medical research","volume":"35","author":"Muka","year":"2020","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.ymgme.2026.110112_bb0115","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.ymgme.2026.110112_bb0120","series-title":"Introduction to Meta-Analysis","author":"Borenstein","year":"2009"},{"key":"10.1016\/j.ymgme.2026.110112_bb0125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11121-013-0377-7","article-title":"Meta-analysis and subgroups","volume":"14","author":"Borenstein","year":"2013","journal-title":"Prev. Sci."},{"key":"10.1016\/j.ymgme.2026.110112_bb0130","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.parkreldis.2014.09.003","article-title":"Glucocerebrosidase mutations in primary parkinsonism","volume":"20","author":"Asselta","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ymgme.2026.110112_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-016-0097-0","article-title":"Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson\u2019s disease","volume":"11","author":"Benitez","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ymgme.2026.110112_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.135816","article-title":"Identification of GBA mutations among neurodegenerative disease patients from eastern India","volume":"751","author":"Biswas","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymgme.2026.110112_bb0145","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.neurobiolaging.2007.11.016","article-title":"Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal","volume":"30","author":"Bras","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ymgme.2026.110112_bb0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2012.02.035","article-title":"Association of mutations in the glucocerebrosidase gene with Parkinson disease in a Korean population","volume":"514","author":"Choi","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymgme.2026.110112_bb0155","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neulet.2016.07.008","article-title":"Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson\u2019s disease and increase susceptibility to dementia in a Flanders-Belgian cohort","volume":"629","author":"Crosiers","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymgme.2026.110112_bb0160","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/mds.21892","article-title":"Glucocerebrosidase gene mutations are associated with Parkinson\u2019s disease in southern Italy","volume":"23","author":"De Marco","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ymgme.2026.110112_bb0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1590\/0004-282x20190006","article-title":"GBA mutations p.n370s and p.l444p are associated with Parkinson\u2019s disease in patients from northern Brazil","volume":"77","author":"De Melo Amaral","year":"2019","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.ymgme.2026.110112_bb0170","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1002\/mds.28112","article-title":"A large-scale full GBA1 gene screening in Parkinson\u2019s disease in the Netherlands: 18 novel and 1 \u2018dutch\u2019 variant","volume":"35","author":"Den Heijer","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ymgme.2026.110112_bb0175","doi-asserted-by":"crossref","first-page":"267.e7","DOI":"10.1016\/j.neurobiolaging.2018.06.027","article-title":"Mutation analysis of Parkinson\u2019s disease genes in a Russian data set","volume":"71","author":"Emelyanov","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ymgme.2026.110112_bb0180","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/cge.12084","article-title":"The L444P GBA mutation is associated with early-onset Parkinson\u2019s disease in Mexican Mestizos","volume":"84","author":"Gonzalez-Del Rincon Mde","year":"2013","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2026.110112_bb0185","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.parkreldis.2011.11.028","article-title":"Glucocerebrosidase N370S and L444P mutations as risk factors for Parkinson\u2019s disease in Brazilian patients","volume":"18","author":"Guimaraes Bde","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ymgme.2026.110112_bb0190","doi-asserted-by":"crossref","first-page":"1765.e1","DOI":"10.1016\/j.neurobiolaging.2014.12.030","article-title":"Polygenic determinants of Parkinson\u2019s disease in a Chinese population","volume":"36","author":"Guo","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ymgme.2026.110112_bb0195","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/00207454.2015.1023436","article-title":"Mutations in the glucocerebrosidase gene are common in patients with Parkinson\u2019s disease from eastern Canada","volume":"126","author":"Han","year":"2016","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.ymgme.2026.110112_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-025-00997-y","article-title":"Penetrance of Parkinson\u2019s disease in GBA1 carriers depends on variant severity and polygenic background","volume":"11","author":"Hassanin","year":"2025","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.ymgme.2026.110112_bb0205","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1468-1331.2011.03362.x","article-title":"Contribution of glucocerebrosidase mutation in a large cohort of sporadic Parkinson\u2019s disease in Taiwan","volume":"18","author":"Huang","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ymgme.2026.110112_bb0210","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neulet.2009.01.029","article-title":"Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece","volume":"452","author":"Kalinderi","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymgme.2026.110112_bb0215","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1468-1331.2012.03817.x","article-title":"Glucocerebrosidase mutations in a Serbian Parkinson\u2019s disease population","volume":"20","author":"Kumar","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ymgme.2026.110112_bb0220","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/hmg\/ddq454","article-title":"Large-scale screening of the Gaucher\u2019s disease-related glucocerebrosidase gene in Europeans with Parkinson\u2019s disease","volume":"20","author":"Lesage","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2026.110112_bb0225","doi-asserted-by":"crossref","first-page":"935.e3","DOI":"10.1016\/j.neurobiolaging.2013.09.019","article-title":"Clinicogenetic study of GBA mutations in patients with familial Parkinson\u2019s disease","volume":"35","author":"Li","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ymgme.2026.110112_bb0230","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neulet.2009.12.007","article-title":"Association between GBA L444P mutation and sporadic Parkinson\u2019s disease from mainland China","volume":"469","author":"Mao","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymgme.2026.110112_bb0235","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archneurol.2007.68","article-title":"Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders","volume":"65","author":"Mata","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2026.110112_bb0240","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archneurol.2009.72","article-title":"Mutations for Gaucher disease confer high susceptibility to Parkinson disease","volume":"66","author":"Mitsui","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2026.110112_bb0245","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ymgme.2011.06.015","article-title":"\u03b2-glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson\u2019s disease","volume":"104","author":"Moraitou","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110112_bb0250","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/ane.13329","article-title":"Community-based genetic study of Parkinson\u2019s disease in Estonia","volume":"143","author":"Muldmaa","year":"2021","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.ymgme.2026.110112_bb0255","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awp044","article-title":"Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2026.110112_bb0260","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1017\/S0317167100012300","article-title":"Glucocerebrosidase mutations in a French-Canadian Parkinson\u2019s disease cohort","volume":"38","author":"Noreau","year":"2011","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.ymgme.2026.110112_bb0265","article-title":"Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson\u2019s study","volume":"9","author":"Pachchek","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.ymgme.2026.110112_bb0270","first-page":"39","article-title":"Glucocerebrosidase genetic variants in Malays with early and late-onset Parkinson\u2019s disease","volume":"25","author":"Pakarulrazy","year":"2020","journal-title":"Neurol. Asia"},{"key":"10.1016\/j.ymgme.2026.110112_bb0275","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.parkreldis.2014.06.007","article-title":"Glucocerebrosidase mutations in Thai patients with Parkinson\u2019s disease","volume":"20","author":"Pulkes","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ymgme.2026.110112_bb0280","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neurobiolaging.2016.04.022","article-title":"Strong association between glucocerebrosidase mutations and Parkinson\u2019s disease in Sweden","volume":"45","author":"Ran","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ymgme.2026.110112_bb0285","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejmg.2018.05.005","article-title":"Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson\u2019s disease","volume":"62","author":"Ruskey","year":"2019","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2026.110112_bb0290","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/mds.20319","article-title":"Analysis of the glucocerebrosidase gene in Parkinson\u2019s disease","volume":"20","author":"Sato","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ymgme.2026.110112_bb0295","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/mds.24045","article-title":"Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson\u2019s disease course","volume":"27","author":"Seto-Salvia","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ymgme.2026.110112_bb0300","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.parkreldis.2007.06.010","article-title":"Association between Parkinson\u2019s disease and glucocerebrosidase mutations in Brazil","volume":"14","author":"Spitz","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ymgme.2026.110112_bb0305","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000523","article-title":"The SPID-GBA study: sex distribution, penetrance, incidence, and dementia in GBA-PD","volume":"6","author":"Straniero","year":"2020","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.ymgme.2026.110112_bb0310","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/mds.23009","article-title":"Glucocerebrosidase gene L444P mutation is a risk factor for Parkinson\u2019s disease in Chinese population","volume":"25","author":"Sun","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ymgme.2026.110112_bb0315","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1001\/archneur.64.7.1056","article-title":"Glucocerebrosidase mutations and risk of Parkinson disease in Chinese patients","volume":"64","author":"Tan","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2026.110112_bb0320","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1212\/01.wnl.0000196492.80676.7c","article-title":"Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population","volume":"66","author":"Toft","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2026.110112_bb0325","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neulet.2015.11.001","article-title":"An assessment of the frequency of mutations in the GBA and VPS35 genes in Hungarian patients with sporadic Parkinson\u2019s disease","volume":"610","author":"Torok","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymgme.2026.110112_bb0330","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.parkreldis.2019.01.030","article-title":"The distribution and risk effect of GBA variants in a large cohort of PD patients from Colombia and Peru","volume":"63","author":"Velez-Pardo","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ymgme.2026.110112_bb0335","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1744-9081-8-57","article-title":"Glucocerebrosidase L444P mutation confers genetic risk for Parkinson\u2019s disease in Central China","volume":"8","author":"Wang","year":"2012","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.ymgme.2026.110112_bb0340","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/jnnp.2006.105940","article-title":"Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese","volume":"78","author":"Wu","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2026.110112_bb0345","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.parkreldis.2017.09.021","article-title":"Genetic risk factors in Finnish patients with Parkinson\u2019s disease","volume":"45","author":"Ylonen","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ymgme.2026.110112_bb0350","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/jhg.2014.110","article-title":"Mutations in the glucocerebrosidase gene are responsible for Chinese patients with Parkinson\u2019s disease","volume":"60","author":"Yu","year":"2015","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2026.110112_bb0355","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4077\/CJP.2012.BAA076","article-title":"Association of common variants in the glucocerebrosidase gene with high susceptibility to Parkinson\u2019s disease among Chinese","volume":"55","author":"Zhang","year":"2012","journal-title":"Chin. J. Phys."},{"key":"10.1016\/j.ymgme.2026.110112_bb0360","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-023-00571-4","article-title":"Mutational spectrum and clinical features of GBA1 variants in a Chinese cohort with Parkinson\u2019s disease","volume":"9","author":"Zhou","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.ymgme.2026.110112_bb0365","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ymgme.2007.03.004","article-title":"Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease","volume":"91","author":"Ziegler","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110112_bb0370","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-comment2007","article-title":"Categorization of humans in biomedical research: genes, race and disease","volume":"3","author":"Risch","year":"2002","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymgme.2026.110112_bb0375","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1007\/s10072-022-06031-w","article-title":"Effect of GBA gene variants on clinical characteristics of dementia with Lewy bodies: a review and meta-analyses","volume":"43","author":"Liu","year":"2022","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ymgme.2026.110112_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212021","article-title":"Effects of GBA1 variants and prenatal exposition on the glucosylsphingosine (Lyso-Gb1) levels in Gaucher disease carriers","volume":"25","author":"Szymanska-Rozek","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2026.110112_bb0385","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ymgme.2026.110112_bb0390","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2350-7-69","article-title":"Polymorphisms in the glucocerebrosidase gene and pseudogene urge caution in clinical analysis of Gaucher disease allele c.1448T>C (L444P)","volume":"7","author":"Brown","year":"2006","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.ymgme.2026.110112_bb0395","series-title":"Haploinsufficiency of Lysosomal Enzyme Genes in Alzheimer's Disease","author":"Benitez","year":"2024"},{"key":"10.1016\/j.ymgme.2026.110112_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26115258","article-title":"Olfactory perception in Parkinson\u2019s disease: the impact of GBA1 variants (Sidransky syndrome)","volume":"26","author":"Cohen","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2026.110112_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26073435","article-title":"Sidransky syndrome\u2014GBA1-related Parkinson\u2019s disease and its targeted therapies","volume":"26","author":"Istaiti","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2026.110112_bb0410","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1093\/brain\/awx285","article-title":"Excessive burden of lysosomal storage disorder gene variants in Parkinson\u2019s disease","volume":"140","author":"Robak","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2026.110112_bb0415","series-title":"Penetrance of Parkinson's Disease in GBA1 Carriers is Depending on the Variant Severity and Polygenic Background","author":"Hassanin","year":"2025"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226003951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226003951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:59:48Z","timestamp":1787669988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226003951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1096719226003951"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110112","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between heterozygous GBA1 L444P carrier status and risk of Parkinson's disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110112"}}